Javascript must be enabled to continue!
Transcriptome analysis reveals vimentin-induced disruption of cell-cell associations augments cancer cell migration
View through CrossRef
Abstract
In advanced metastatic cancers with reduced patient survival and poor prognosis, expression of vimentin, a type III intermediate filament protein is frequently observed. Vimentin appears to suppress epithelial characteristics and augments cell migration but the molecular basis for these changes are not well understood. Here we have ectopically expressed vimentin in MCF-7 and investigated its genomic and functional implications. Vimentin changed the cell shape, by decreasing major axis and major axis angle, and increased cell migration, without affecting proliferation. Vimentin downregulated major keratin genes KRT8, KRT18 and KRT19. Transcriptome-coupled GO and KEGG analyses revealed that vimentin-affected genes were linked to either cell-cell/cell-ECM or cell cycle/proliferation specific pathways. Using shRNA mediated knockdown of vimentin in two breast cancer cell types; MCF-7FV (ectopically expressing) and MDA-MB-231 (endogenously expressing), we identified a vimentin-specific signature consisting of 13 protein encoding genes (CDH5, AXL, PTPRM, TGFBI, CDH10, FOXM1, BCL2, NES, E2F1, FOXM1, CDC45, FSD1, BCL2, KIF26A and WISP2) and two long non-coding RNAs, LINC00052 and C15ORF9-AS1. CDH5, an endothelial cadherin, which mediates cell-cell junctions was the most downregulated protein encoding gene. Interestingly, downregulation of CDH5 by shRNA significantly increased cell migration confirming our RNA-Seq data. Furthermore, vimentin reduced MCF-7 nuclear area perhaps through altered lamin expression. Collectively, we demonstrate, for the first time, that vimentin in cancer cells changes nuclear architecture by affecting lamin expression, which downregulates genes maintaining cell-cell junctions resulting in increased cell migration.
Springer Science and Business Media LLC
Title: Transcriptome analysis reveals vimentin-induced disruption of cell-cell associations augments cancer cell migration
Description:
Abstract
In advanced metastatic cancers with reduced patient survival and poor prognosis, expression of vimentin, a type III intermediate filament protein is frequently observed.
Vimentin appears to suppress epithelial characteristics and augments cell migration but the molecular basis for these changes are not well understood.
Here we have ectopically expressed vimentin in MCF-7 and investigated its genomic and functional implications.
Vimentin changed the cell shape, by decreasing major axis and major axis angle, and increased cell migration, without affecting proliferation.
Vimentin downregulated major keratin genes KRT8, KRT18 and KRT19.
Transcriptome-coupled GO and KEGG analyses revealed that vimentin-affected genes were linked to either cell-cell/cell-ECM or cell cycle/proliferation specific pathways.
Using shRNA mediated knockdown of vimentin in two breast cancer cell types; MCF-7FV (ectopically expressing) and MDA-MB-231 (endogenously expressing), we identified a vimentin-specific signature consisting of 13 protein encoding genes (CDH5, AXL, PTPRM, TGFBI, CDH10, FOXM1, BCL2, NES, E2F1, FOXM1, CDC45, FSD1, BCL2, KIF26A and WISP2) and two long non-coding RNAs, LINC00052 and C15ORF9-AS1.
CDH5, an endothelial cadherin, which mediates cell-cell junctions was the most downregulated protein encoding gene.
Interestingly, downregulation of CDH5 by shRNA significantly increased cell migration confirming our RNA-Seq data.
Furthermore, vimentin reduced MCF-7 nuclear area perhaps through altered lamin expression.
Collectively, we demonstrate, for the first time, that vimentin in cancer cells changes nuclear architecture by affecting lamin expression, which downregulates genes maintaining cell-cell junctions resulting in increased cell migration.
Related Results
Woningcorporaties en Vastgoedontwikkeling
Woningcorporaties en Vastgoedontwikkeling
This summary highlights the findings of the PhD-thesis ‘Woningcorporaties en Vastgoedontwikkeling: Fit for Use’ (‘Housing associations and Real Estate Development: Fit for Use?’). ...
Abstract 1538: Vimentin expression as a potential immunomarker of predicting aggressive disease in clear cell renal cell carcinoma
Abstract 1538: Vimentin expression as a potential immunomarker of predicting aggressive disease in clear cell renal cell carcinoma
Abstract
Vimentin is a type III intermediate filament protein that is expressed in mesenchymal cells. Overexpression of vimentin has been detected in prostate cancer...
Abstract 4150: TNFα and TGFβ1 secreted by macrophages enhance breast cancer cell migration dynamics via the induction of NF-κB dependent MMP-1 expression
Abstract 4150: TNFα and TGFβ1 secreted by macrophages enhance breast cancer cell migration dynamics via the induction of NF-κB dependent MMP-1 expression
Abstract
Metastasis, which is a major cause of cancer death, depends on cancer cell's ability to migrate through the dense extracellular matrix (ECM) within the soli...
Relationship of Anti-vimentin antibodies to anti-endothelial antibodies
Relationship of Anti-vimentin antibodies to anti-endothelial antibodies
Abstract
The intermediate filament protein vimentin is a potential target antigen for autoantibodies in some infectious and autoimmune diseases. Because endothelial ...
Conjugate vaccines targeting the tumor vasculature
Conjugate vaccines targeting the tumor vasculature
Cancer cells acquire critical hallmarks which eventually facilitate the formation of malignant tumors. In this thesis, we highlighted two important hallmarks, the induction of angi...
STUDY OF VIMENTIN EXPRESSION IN TRIPLE NEGATIVE BREAST CANCER
STUDY OF VIMENTIN EXPRESSION IN TRIPLE NEGATIVE BREAST CANCER
Background: Breast carcinoma is one of the most common cancer among women globally. Increased vimentin expression has been reported in triple negative breast carcinoma (TNBC) cases...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...

